Shi YX - Search Results

1

Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines.

Luo HY, Wei W, Shi YX, Chen XQ, Li YH, Wang F, Qiu MZ, Li FH, Yan SL, Zeng MS, Huang P, Xu RH. Luo HY, et al. Among authors: shi yx. Oncol Rep. 2010 Jun;23(6):1735-45. doi: 10.3892/or_00000819. Oncol Rep. 2010. PMID: 20428833

2

[Expression and clinical significance of hypoxia-inducible factor-1alpha in gastric cancer].

Han B, Xu RH, Shi YX, Li YH, Luo HY, Wang F, Hou JH, Cai MY, Jiang WQ. Han B, et al. Among authors: shi yx. Ai Zheng. 2006 Nov;25(11):1439-42. Ai Zheng. 2006. PMID: 17094917 Chinese.

3

[Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].

Xu RH, Shi YX, Guan ZZ, Jiang WQ, Huang H, Ma ZY, Wang JH, Hu XH, Xie WM, Li XG, Liu YL, Pan LX, Dai AD, Zhuang W, Zhang C. Xu RH, et al. Among authors: shi yx. Ai Zheng. 2006 Dec;25(12):1565-8. Ai Zheng. 2006. PMID: 17166388 Clinical Trial. Chinese.

4

High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.

Wang F, Xu RH, Han B, Shi YX, Luo HY, Jiang WQ, Lin TY, Huang HQ, Xia ZJ, Guan ZZ. Wang F, et al. Among authors: shi yx. Cancer. 2007 Apr 1;109(7):1360-4. doi: 10.1002/cncr.22549. Cancer. 2007. PMID: 17326056 Free article. Clinical Trial.

5

[Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].

Shi YX, Zhang XS, Xia JC, Li YQ, Xu RH, Han WJ, Zhang JH, Guan ZZ, Jiang WQ. Shi YX, et al. Ai Zheng. 2007 Aug;26(8):837-42. Ai Zheng. 2007. PMID: 17697543 Free article. Chinese.

6

[Efficacy of CPT-11 combined 5-FU/CF (FOLFIRI) regimen on advanced colorectal cancer].

Luo HY, Li YH, Zhang L, Jiang WQ, Shi YX, Wang F, He YJ, Xu RH. Luo HY, et al. Among authors: shi yx. Ai Zheng. 2007 Aug;26(8):905-8. Ai Zheng. 2007. PMID: 17697557 Free article. Chinese.

7

[Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].

Shi YX, Xu RH, Jiang WQ, Zhang L, Lin TY, Li YH, Xia ZJ, Luo HY, Han B, Wang F, He YJ, Guan ZZ. Shi YX, et al. Ai Zheng. 2007 Dec;26(12):1381-4. Ai Zheng. 2007. PMID: 18076807 Free article. Chinese.

8

[A survival of 103 cases of T-cell non-Hodgkin lymphoma].

Shi YX, Peng RJ, Lin SX, Wu QL, Lin TY, Sun XF, Huang HQ, Xia ZJ, Li YH, Xu RH, Liu DG, Guan ZZ, Jiang WQ. Shi YX, et al. Zhonghua Nei Ke Za Zhi. 2007 Dec;46(12):1000-2. Zhonghua Nei Ke Za Zhi. 2007. PMID: 18478916 Chinese.

9

A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.

Luo HY, Xu RH, Zhang L, Li YH, Shi YX, Lin TY, Han B, Wang F, Qiu MZ, He YJ, Guan ZZ. Luo HY, et al. Among authors: shi yx. Chemotherapy. 2008;54(3):228-35. doi: 10.1159/000140467. Epub 2008 Jun 18. Chemotherapy. 2008. PMID: 18560231 Clinical Trial.

10

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

Li YH, Luo HY, Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH. Li YH, et al. Among authors: shi yx. J Cancer Res Clin Oncol. 2010 Apr;136(4):503-10. doi: 10.1007/s00432-009-0682-5. Epub 2009 Sep 24. J Cancer Res Clin Oncol. 2010. PMID: 19777259 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page